Evaluate Common Causes Review sleep, anemia, iron and B12 status, thyroid disease, diabetes, medications, infection, heart or lung disease, depression, nutrition, and substance use when symptoms suggest them
Lee Seward, Christina Beer, and Elisa Barnes (of LifeVantage Corporation) assisted with study design but funding sources had no involvement in data collection and analysis or manuscript preparation
Many patients find sublingual Tirzepatide to be quite affective at appetite suppression and weight loss, while others find it less effective than subcutaneous injections
Its additional antioxidant and neuroprotective properties have also made it a subject of interest in age-related cognitive support
Mike Clark and Dr
Results: The obtained data revealed that PPA treatment caused significant oxidative stress and neurotransmitter imbalances, characterized by reduced GABA and elevated glutamate levels